Laboratory controls shall include the establishment of scientifically sound and appropriate specifications, standards, sampling plans, and test procedures designed to assure that components, drug product containers, closures, in-process materials, labeling, and drug products conform to appropriate standards ofidentity, strength, quality, and purity.
Inspection Record
Strides Pharma Science Limited — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Each component is not tested for conformity with all written specifications for purity, strength, and quality.
All records of production associated with a batch of drug product were not maintained at least one (1) year after the expiration date.
Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.
Your firm failed to exercise controls over computerized manufacturing equipment to ensure that only authorized personnel can create and modify recipes, that obsolete or unauthorized recipes cannot be selected for commercial manufacturing, and that accurate data input is maintained across your facility's computerized systems.
About this record
Extracted automatically from the document US FDA published on 2026-07-28. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
